Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Change in Receivables data on file, last reported at -$11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 25.79% year-over-year to -$11.7 million; the trailing twelve-month figure through Mar 2026 stood at -$306000.0 (down 107.25% YoY), and the FY2025 full-year result was $2.1 million, down 63.25% from the prior year.
• Change in Receivables for Q1 2026 stood at -$11.7 million, down from $9.5 million in the prior quarter.
• Across five years, Change in Receivables topped out at $17.2 million in Q4 2024 and bottomed at -$11.7 million in Q1 2026.
• The 5-year median for Change in Receivables is -$696000.0 (2025), against an average of $966588.2.
• The widest annual swing landed in 2023, when Change in Receivables jumped 343.49%; it then plunged 229.84% in 2024.
• A 5-year view of Change in Receivables shows it stood at $11.1 million in 2022, then climbed by 20.95% to $13.4 million in 2023, then rose by 28.09% to $17.2 million in 2024, then tumbled by 44.64% to $9.5 million in 2025, then sank by 222.77% to -$11.7 million in 2026.
• The last three Change in Receivables figures came in at -$11.7 million (Q1 2026), $9.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.

Peer Comparison